![Kendall Mohler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kendall Mohler
Corporate Officer/Principal bei ALSP ORCHID ACQUISITION CORPORATION I
Ursprung des Netzwerks ersten Grades von Kendall Mohler
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Accelerator Services Corp
![]() Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.
39
| Holding Company | Investment Managers | 39 |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation
30
| Subsidiary | Biotechnology | 30 |
Subsidiary | Biotechnology | 26 | |
Private Company | Financial Conglomerates | 11 | |
Neuvogen, Inc.
4
| Private Company | 4 | |
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kendall Mohler
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Administrative Officer Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO General Counsel Corporate Officer/Principal | |
ICOS Corp.
![]() ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Corporate Officer/Principal General Counsel President | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer President | |
Corixa Corp.
![]() Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | General Counsel Chief Executive Officer Corporate Officer/Principal | |
SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Renovis, Inc.
![]() Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
Roche Pharmaceuticals, Inc.
![]() Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer President | |
OMEROS CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Global Alliance for TB Drug Development
![]() Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Graduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Corporate Officer/Principal Founder Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
California Institute of Technology
![]() California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Doctorate Degree Doctorate Degree | |
University of Iowa | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Michigan | College/University | Chairman Masters Business Admin Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
The Rockefeller University | College/University | Director/Board Member Doctorate Degree President Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Fred Hutchinson Cancer Research Center
![]() Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Washington Biotechnology & Biomedical Association | Director/Board Member Chairman Director/Board Member | ||
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Founder Chief Executive Officer Director/Board Member | |
Acylin Therapeutics, Inc.
![]() Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member Director/Board Member | |
ImmusanT, Inc.
![]() ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Founder Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Lodo Therapeutics Corp.
![]() Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Founder | |
Petra Pharma Corp.
![]() Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer | |
Proniras Corp.
![]() Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Founder | |
Magnolia Neurosciences Corp.
![]() Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer Director/Board Member Private Equity Investor | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Founder General Counsel Director/Board Member General Counsel Public Communications Contact Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Mozart Therapeutics, Inc.
![]() Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Chairman Director/Board Member | |
Hc Bioscience, Inc.
![]() Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Chairman Founder |
Statistik
International
Vereinigte Staaten | 49 |
Schweiz | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 32 |
Consumer Services | 14 |
Commercial Services | 5 |
Finance | 2 |
Operativ
Director/Board Member | 539 |
Corporate Officer/Principal | 264 |
Independent Dir/Board Member | 113 |
Undergraduate Degree | 91 |
Chief Tech/Sci/R&D Officer | 84 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Steven Gillis | 58 |
Joel Marcus | 57 |
Anthony Evnin | 46 |
Maggie Wilderotter | 44 |
Thomas Daniel | 35 |
Leroy Hood | 34 |
Alan Frazier | 31 |
Thong Le | 30 |
Howard H. Pien | 27 |
Bruce Carter | 25 |
Marc Tessier-Lavigne | 24 |
Wendy Johnson | 23 |
Sundar Kodiyalam | 21 |
Jan Lundberg | 21 |
Jinzi Wu | 20 |
- Börse
- Insiders
- Kendall Mohler
- Unternehmensverbindungen